Articles from InterVene, Inc.

InterVene, Inc., a medical device company pioneering interventional devices for venous inflow and outflow obstructions, announced today that the first patient has been treated with its Recana Thrombectomy Catheter System for venous in-stent restenosis (ISR). The Recana System is the first fully integrated mechanical thrombectomy system designed specifically to address the long-term complications of venous disease, including ISR and native vein obstructions. The case was performed at University Hospital Galway in Galway, Ireland, by Dr. Gerry O’Sullivan, consultant interventional radiologist.

InterVene, Inc., a clinical-stage medical device company dedicated to developing interventional solutions for chronic venous insufficiency (CVI), announced today the closing of its $13M Series A financing round. The financing was co-led by new investor Treo Ventures and existing investor RiverVest Venture Partners®. In conjunction with this financing, Brad Vale, Treo Ventures founding general partner, has joined InterVene’s Board of Directors.